Pulmonology
The efficacy and safety of DW1601 in patients with acute bronchitis: a multi-center, randomized, double-blind, phase III clinical trial
Young Seok Lee, Seong Yong Lim, Kyung Hoon Min, Do Jin Kim, Kwang Ha Yoo, Tae-Bum Kim, Hak-Ryul Kim, Jae Jeong Shim
Korean J Intern Med. 2022;37(6):1195-1204. Published online September 26, 2022
Background/Aims: DW1601, an oral fixed dose combination syrup composed of DW16011 and Pelargonium sidoides, was developed to enhance the symptom relief effect in patients with acute bronchitis. We evaluated the efficacy and safety of DW1601 compared to DW16011 or P. sidoides for treatm..
|